Apex gets approval for ‘world’s largest’ take home psychedelic trial 23-Jan-2023 By Ben Hargreaves The company plans to conduct a Phase 2b trial to test its APEX-52 psilocybin drug candidate to treat adults with post-traumatic stress disorder.